SCHEMBL7799219

SCHEMBL7799219

O=CNC(CSSCC(NC=O)C(=O)NCc1ccccc1)C(=O)NCc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MME P08473 1/20 0.49
CA12 O43570 1/20 0.48
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
CA3 P07451 1/20 0.48
CA4 P22748 1/20 0.48
CA6 P23280 1/20 0.48
CA5A P35218 1/20 0.48
CA7 P43166 1/20 0.48
CACNA1C Q13936 1/20 0.48
SCN9A Q15858 1/20 0.48
CA9 Q16790 1/20 0.48
CA13 Q8N1Q1 1/20 0.48
CA14 Q9ULX7 1/20 0.48
CA5B Q9Y2D0 1/20 0.48
MMP8 P22894 2/20 0.46
KMT2A Q03164 1/20 0.46
CYP2D6 P10635 2/20 0.45
ALDH1A1 P00352 3/20 0.44
LMNA P02545 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7799221 0.87 MME (0.42) MMECA12CA1CA2CA3
SCHEMBL7798914 0.86 POLB (0.48) CA12CA2CA9KMT2ACYP2D6
SCHEMBL7349415 0.84 CA12 (0.49) CA12CA1CA2CA3CA4
SCHEMBL13085992 0.81 CA12 (0.68) MMECA12CA1CA2CA3
SCHEMBL14091688 0.80 CA12 (0.49) MMECA12CA1CA2CA3
SCHEMBL7799228 0.78 MME (0.40) MMECA12CA1CA2CA3
SCHEMBL9915143 0.76 CA12 (0.65) MMECA12CA1CA2CA3
SCHEMBL16289738 0.74 CA12 (0.49) MMECA12CA1CA2CA3
SCHEMBL16463228 0.73 CAPN1 (0.53) KMT2AALDH1A1ANPEPEPHX1L3MBTL1
SCHEMBL14091963 0.73 CTSS (0.60) CA12CA1CA2CA3CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1143960-A2 CYSTINE DERIVATIVES AS THERAPEUTIC AGENTS FOR MATRIX METALLOPROTEASE RELATED DISEASES Roche Diagnostics GmbH (DE) 2001-10-17 EP disclosed
WO-2000027378-A2 CYSTINE DERIVATIVES AS THERAPEUTIC AGENTS FOR MATRIX METALLOPROTEASE RELATED DISEASES ROCHE DIAGNOSTICS GMBH (DE) 2000-05-18 WO disclosed